Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...
The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...
Marketing: Around the world, brands have learnt that revamping their identities without thinking the exercise through can be met with ridicule and derision — often the hard way. On the other hand, ...
The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...
In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...
We recently published a list of the Top 10 Small Cap Stocks to Buy with the Highest Upside Potential. In this article, we are ...
A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.
In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
In a footnote of his opinion, Judge Joshua Roberts wrote, “A more cynical view of the circumstances is that plaintiffs’ ...
The H5N1 bird flu has been reported to have caused the death of a patient in Louisiana. Such a case poses a significant ...
The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...